Holen Sie sich die Stockscreener-App
7.47
1.08%
0.08
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BHC?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Bausch Health Companies Inc Aktie (BHC) Neueste Nachrichten
Bausch + Lomb confirms potential sale is 'one of several options being explored' - MSN
Zacks Research Has Optimistic Outlook of BHC Q3 Earnings - MarketBeat
FY2024 EPS Estimates for TSE:BHC Raised by Zacks Research - MarketBeat
Zacks Research Issues Optimistic Forecast for BHC Earnings - MarketBeat
Is Bausch Health Companies (BHC) Among Billionaire Paul Singer’s Top Long-Term Stock Picks? - Yahoo Finance
Bausch Health Companies Inc. (NYSE:BHC) Stock Position Reduced by Franklin Resources Inc. - MarketBeat
Bausch Health's SWOT analysis: debt woes cloud strong q3 for diverse pharma stock - Investing.com
Canada: Bausch Health responds to rumours of potential sale of Bausch + Lomb - Investors in Healthcare
Bausch Health Companies Inc. (NYSE:BHC) Short Interest Up 9.9% in November - MarketBeat
Bausch + Lomb responds to rumors of a potential sale - The Pharma Letter
Bausch Health tanks 23.3% on unconfirmed report of bankruptcy filing - MSN
Bausch And Lomb Says Potential Sale In The Works - Law360
Contact lens maker Bausch + Lomb says it is exploring sale - Reuters
Bausch + Lomb confirms it is exploring a potential sale - Financial Post
Bausch & Lomb edges higher after confirming sales process - MSN
Bausch + Lomb Explores Potential Sale - Mergers & Acquisitions
Bausch + Lomb exploring several options including a potential sale - MSN
Bausch Health Companies Inc. - Baystreet.ca
Bausch + Lomb is exploring a potential sale - Mass Device
Bausch + Lomb responds to rumors of potential sale - Rochester Business Journal
Bausch Says Potential Sale of Bausch + Lomb Still On Table - MarketWatch
Bausch + Lomb Confirms It Is Exploring a Potential Sale - Bloomberg
Bausch Health Responds to Rumors of a Potential Sale of Bausch + Lomb - AccessWire
Bausch + Lomb Responds to Rumors of a Potential Sale - Business Wire
Eye health company Bausch + Lomb’s affiliate acquires Elios Vision - Yahoo! Voices
Stocks In Play: Bausch Health Companies Inc. - Barchart
Bausch Health Companies' SWOT analysis: debt woes cloud strong Q3 stock performance - Investing.com
Bausch + Lomb Shares Down on Report That Potential Buyer May Back Out - MarketWatch
Bausch + Lomb dips on rumour of failing takeover talks - pharmaphorum
XTX Topco Ltd Buys Shares of 114,898 Bausch Health Companies Inc. (NYSE:BHC) - MarketBeat
Intraocular Lens Market Future Business Opportunities - openPR
Why Is Bausch Health Companies Inc. (BHC) Among the Best Cosmetic Surgery and Aesthetics Stocks to Invest In Now? - Yahoo Finance
Bausch + Lomb buyout teeters as Blackstone balks at price tag - Financial Times
Epinephrine Autoinjector Market to Grow by USD 2.44 Billion (2024-2028), Driven by Rising Allergy Prevalence and AI-Powered Market TransformationTechnavio - The Malaysian Reserve
Verition Fund Management LLC Takes $808,000 Position in Bausch Health Companies Inc. (NYSE:BHC) - MarketBeat
Bausch Health : + Lomb Reports Nearly 27 Million Units of Contact Lens Materials Recycled Through One By One Recycling Program - Marketscreener.com
Bausch + Lomb And Bausch Health: Some Incremental Progress As We Wait For Sale News (BLCO) - Seeking Alpha
116,591 Shares in Bausch Health Companies Inc. (NYSE:BHC) Acquired by Centiva Capital LP - MarketBeat
Readystate Asset Management LP Grows Position in Bausch Health Companies Inc. (NYSE:BHC) - MarketBeat
Bausch Health and Salix in Collaboration with Health Organizations Recognize the Second Annual Opioid-Induced Constipation (OIC) Awareness Day - Eagle-Tribune
Bausch Health Leads OIC Awareness Campaign: Tackling Critical Side Effect of Opioid Treatment - StockTitan
Medical Aesthetic Device Market is expected to grow at a CAGR - openPR
Body Contouring Devices Market: Company Profiles, Trends, - openPR
Hepatic Encephalopathy Market Report 2034: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Salix Pharmaceuticals, Bausch Health, Axcella Health, Inc., Umecrine - The Globe and Mail
Maple Rock Capital Partners Inc. Makes New Investment in Bausch Health Companies Inc. (NYSE:BHC) - MarketBeat
Global Healthcare & Medical Tourism News - Medical Tourism Magazine
Bausch Health names Jonathan Sadeh as chief medical officer - MSN
Bausch Health Companies: Improving Core Business Cures Its Bankruptcy Rumors - Seeking Alpha
Bausch Health Taps Jonathan Sadeh as Chief Medical Officer - MarketWatch
Bausch Health Appoints New Chief Medical Officer and Head of R&D - Batesville Daily Guard
Quantbot Technologies LP Acquires Shares of 101,543 Bausch Health Companies Inc. (NYSE:BHC) - MarketBeat
Anti-Vascular Endothelial Growth Factor Therapeutics Market - openPR
Goldentree Asset Management LP Has $239.55 Million Holdings in Bausch Health Companies Inc. (NYSE:BHC) - MarketBeat
Why Bausch Health Companies (BHC) is One of the Best Canadian Stocks to Buy Under $10? - Yahoo Finance
10 Best Canadian Stocks to Buy Under $10 - Insider Monkey
Dermatological OTC Drugs Market Growing Trends and Technology - openPR
Bausch Health Companies Inc. (NYSE:BHC) is largely controlled by institutional shareholders who own 56% of the company - Simply Wall St
1.61%
1.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):